Although anti-neutrophil antibodies (ANAs) often exist and immunoreaction may be involved in agranulocytosis, few reports have so far described ANA-positive cases of agranulocytosis with an unknown etiology. We herein describe the case of a 69-year-old woman who presented with ANA-positive agranulocytosis. In this case, both the withdrawal of the drugs that had possibly caused neutropenia and the use of granulocyte-colony stimulating factor (G-CSF) were ineffective treatment measures. Approximately 2 weeks after the discontinuation of the suspected drugs, we initiated corticosteroid pulse therapy; the neutrophil count recovered by day 19 of steroid therapy. High-dose methylprednisolone therapy should thus be considered for patients demonstrating ANA-positive agranulocytosis with an unknown etiology that is refractory to G-CSF treatment.
CITATION STYLE
Koh, S., Koh, H., Kubo, Y., Kuroda, M., Nishimoto, M., Yoshimura, T., … Hino, M. (2017). An elderly woman with anti-neutrophil antibody-positive agranulocytosis who responded to high-dose intravenous methylprednisolone. Internal Medicine, 56(16), 2199–2203. https://doi.org/10.2169/internalmedicine.8268-16
Mendeley helps you to discover research relevant for your work.